Air pollution in China has reached alarming levels. Recent near-zero visibility in Beijing forced China to issue a red alert that curtailed vehicle use and shut down factories, according to a CNN report. Not surprisingly, Beijing officials have reported a more than 63% rise in lung cancer over the past decade, according to Medical Daily. While cigarette smoking certainly plays a role, experts say chronic air pollution is becoming a major risk factor for lung cancer and a likely cause of increasing lung cancer rates among non-smokers. Lung cancer is now the No. 1 cancer killer in China.
“There are lots of carcinogens emitted with industrial pollution,” C. Arden Pope of Brigham Young University told National Geographic. “Our respiratory systems filter out the relatively large particles from air pollution … The tiny ones come nearly entirely from burning things – coal, gasoline and diesel. Those tiny combustion particles are small enough to penetrate the lungs, and they’re made up of all sorts of nasty particles.”
Following 9/11, clouds of airborne particulate were blamed for the sharp spike in cancer cases, including lung cancer, among first responders and people who lived or worked near the site of the World Trade Towers.
Interestingly, airborne pollution from cigarette smoke or industrial pollutants doesn’t pose the only lung cancer risk. High levels of arsenic in drinking water are a major risk factor for a form of lung cancer that appears to be linked to the tumor microenvironment. Issels’ non-toxic cancer vaccines are unique in that they attack not only the cancer tumor but the surrounding tumor microenvironment. Visit our website for more information.
If you answered breast cancer, you are not alone; but you would be wrong. Most women are surprised to find out that lung cancer is the deadliest type of cancer for women. Lung cancer accounts for nearly 40% of all cancer deaths among women, compared to 22% for breast cancer and 13% for colorectal cancer, the third leading cause of cancer death among women, according to the U.S. Centers for Disease Control and Prevention.
Perhaps because breast cancer receives so much press and is so obviously linked to women, many people assume that breast cancer poses women’s greatest cancer fatality risk. However, while it is the most common “female” cancer, breast cancer is only the second leading cause of cancer death among women and is one of the more treatable forms of cancer. (Among women of Hispanic heritage, breast cancer is the No. 1 cancer killer with lung cancer running a close second.) Particularly when discovered early, breast cancer frequently offers a high rate of successful long-term remission. As Issels treatment cases indicate, even when discovered late, integrated immunotherapy has helped many breast cancer patients achieve long-term remission.
November is Lung Cancer Awareness Month, an excellent opportunity to discuss risk factors and treatment options for the cancer that causes more deaths among women than breast, uterine and ovarian cancer combined! While smoking is the primary cause of lung cancer, the disease also strikes many women who have never smoked. As it has for women with breast cancer, Issels personalized immunotherapy has also helped numerous lung cancer patients achieve successful remission.
With all the publicity breast cancer and prostate cancer receive, many people assume they are the top cancer killers in the U.S. While breast and prostate cancers are the two most frequently diagnosed cancers, lung cancer, only third in number of diagnoses, actually kills twice as many people as its more common cousins.
Current and former smokers comprise the majority of lung cancer victims, but non-smokers are also at risk, particularly if they have lived with a smoker or worked in a smoke-filled environment. In some cases, the dangers of second-hand smoke can elevate cancer risk to the same level of cigarette smokers.
The bad news for lung cancer victims is that the 15% 5-year survival rate has remained unchanged over the past four decades, despite the tremendous progress in cancer diagnosis and treatment that has resulted in greatly improved cancer survival rates for many other types of cancer.
Symptoms that mimic common respiratory illnesses and the late arrival of symptoms make early detection of lung cancer difficult. Researchers have been working to develop better screening procedures that could prompt earlier lung cancer discovery and treatment. At Stanford University, researchers have had some success using a lung CT scan to diagnose lung cancer. Among study participants, early detection improved lung cancer survival rates by 20%, but the high level of false positives (95%) remains problematic.